Maximize Your Impact at ESMO Congress 2025
ESMO Congress 2025, taking place October 17–21 at Messe Berlin in Berlin, Germany, is one of the year’s most influential gatherings focused on medical oncology and cancer research. With a global draw of clinicians, pharmaceutical executives, biotech innovators, and healthcare decision-makers, this event serves as a strategic platform for driving advancements in oncology treatment and care.
Senior-level professionals attending the conference are responsible for clinical trial strategy, oncology pipeline development, medical affairs leadership, and health policy implementation. These attendees carry decision-making authority over research collaborations, licensing partnerships, and budget allocations for emerging therapies. Teams using Vendelux’s enriched attendee list can pinpoint which cancer center directors, medical affairs leads, or heads of research and development are going—and why early, informed outreach can make the difference between a missed opportunity and a long-term partnership.
How Sales, Marketing and RevOps Teams Can Use This Attendee List
Pharmaceutical, biotech, and healthcare solution providers attending ESMO Congress 2025 can use the enriched conference attendee list to prepare highly targeted outreach informed by role, institution type, and clinical focus. Sales teams can identify leaders from top oncology hospitals or global pharma with upcoming budget cycles, while marketing teams can tailor messaging based on each attendee’s therapeutic area or clinical responsibilities.
RevOps teams benefit by aligning internal workflows around verified outreach windows, ensuring commercial staff connect on time with medical affairs directors or procurement leaders. The data simplifies how to get more meetings by surfacing contacts from key accounts, allowing outreach to reflect specific cancer research initiatives, joint venture opportunities, or ongoing trials. After the event, teams can follow up more effectively by referencing relevant consortium announcements, abstracts presented, or booth interactions that align with their value proposition.
Timing Is Everything
ESMO Congress 2025 is scheduled for October 17–21, 2025. With many attendees finalizing partnerships and scientific evaluations before arriving in Berlin, early engagement is critical. Vendelux gives commercial teams a head start with attendee visibility well before badges are printed, allowing teams to prioritize outreach windows aligned with procurement timelines, late-breaking abstracts, or poster sessions.
Meetings secured 30–60 days before the event can be better aligned with scheduling and R&D agendas. Whether your team is planning private meetings, symposia support, or product theater invitations, proactively using the attendee list now increases visibility and relevance on-site.
What’s Included In The ESMO Congress 2025 Attendee List?
Vendelux provides visibility into executives attending ESMO Congress 2025 through a combination of organizer data and proprietary predictive insights. Clients can upload a list of target accounts to see confirmed or projected attendee matches.
The enriched list contains first and last names, job titles, company names, company websites, cities, states, countries, LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is ESMO Congress 2025?
The event will be held at Messe Berlin in Berlin, Germany.
When Is ESMO Congress 2025?
ESMO Congress 2025 is scheduled to take place October 17–21, 2025.
What Type Of Event Is ESMO Congress 2025?
ESMO Congress 2025 is a leading global medical conference centered on advancements in clinical oncology. It features scientific presentations, poster sessions, keynote addresses from renowned oncology experts, and high-level discussions across the pharmaceutical and medical research industries. The event offers significant networking opportunities for life sciences professionals looking to connect with peers, partners, and thought leaders.
How Many People Attend ESMO Congress 2025?
ESMO Congress 2025 is expected to attract more than 30,000 attendees from over 130 countries, including oncologists, cancer researchers, pharmaceutical executives, CRO representatives, and regulatory policymakers. Many of these attendees hold director-level or higher roles across clinical, medical, and commercial functions.
